Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Morea

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2016
Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractorinessGiulio Fracasso, Elisabetta Falvo, Gianni Colotti, et al.
International Journal of Molecular Sciences|February 2, 2021
Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived CellsTheo Battista, Gianmarco Pascarella, David Sasah Staid, et al.
Human Molecular Genetics|January 2, 2016
Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutationsElena Perli, Annarita Fiorillo, Carla Giordano, et al.
Scientific Reports|March 27, 2019
Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacementElena Perli, Annalinda Pisano, Ruth I C Glasgow, et al.
EMBO Molecular Medicine|January 14, 2014
The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cellsElena Perli, Carla Giordano, Annalinda Pisano, et al.
Human Molecular Genetics|September 28, 2011
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathyElena Perli, Carla Giordano, Helen A L Tuppen, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2016
Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractorinessGiulio Fracasso, Elisabetta Falvo, Gianni Colotti, et al.
International Journal of Molecular Sciences|February 2, 2021
Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived CellsTheo Battista, Gianmarco Pascarella, David Sasah Staid, et al.
Human Molecular Genetics|January 2, 2016
Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutationsElena Perli, Annarita Fiorillo, Carla Giordano, et al.
Scientific Reports|March 27, 2019
Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacementElena Perli, Annalinda Pisano, Ruth I C Glasgow, et al.
EMBO Molecular Medicine|January 14, 2014
The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cellsElena Perli, Carla Giordano, Annalinda Pisano, et al.
Human Molecular Genetics|September 28, 2011
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathyElena Perli, Carla Giordano, Helen A L Tuppen, et al.
Pageof 7